| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And COO | Chief Business Officer | See Remarks
2 companies
McNeill Jonathan is a President And COO at CBIO with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | DYN Dyne Therapeutics, Inc. | Chief Business Officer | Sell | 1,266 | $10.41 | $13,179.06 | -2.0% | +10.1% | +229.3% | |
| Jun 13, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 2,259 | $12.68 | $28,649.37 | -1.7% | -13.1% | +156.5% | |
| Mar 14, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 2,209 | $13.18 | $29,115.97 | -1.6% | -7.3% | +105.7% | |
| Jan 18, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sale+OE | 10,000 | $14.03 | $140,300.00 | -12.9% | -29.6% | +17.2% | |
| Jan 9, 2023 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 30,150 | $11.57 | $348,835.50 | -30.8% | -23.0% | +63.9% | |
| Dec 12, 2022 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 472 | $10.87 | $5,130.64 | -0.5% | +13.1% | -5.9% | |
| Mar 11, 2022 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 481 | $8.73 | $4,199.13 | -0.8% | -38.6% | +49.8% | |
| Sep 21, 2021 | DYN Dyne Therapeutics, Inc. | See Remarks | Sell | 1,274 | $15.90 | $20,251.64 | -1.7% | -23.9% | -16.3% |